Related Experiment Video
Updated: Jul 30, 2026
11:37
In vitro Enrichment of Ovarian Cancer Tumor-initiating Cells
Published on: February 18, 2015
14.3K
The National Cancer Institute's Efforts in Promoting Research in the Tumor Microenvironment
Nastaran Z Kuhn1, Elisa C Woodhouse, Suresh Mohla
1From the Division of Cancer Biology, National Cancer Institute, National Institutes of Health, Rockville, MD.
Cancer Journal (Sudbury, Mass.)
|July 30, 2015
Summary
The National Cancer Institute funds research into the tumor microenvironment. This research enhances understanding of cancer progression and therapeutic resistance.
Area of Science:
- Oncology
- Cancer Biology
- Systems Biology
Background:
- The National Cancer Institute has supported tumor microenvironment research since 1993.
- The tumor microenvironment plays a crucial role in cancer progression and therapeutic resistance.
Purpose of the Study:
- To foster research into the tumor microenvironment.
- To understand the tumor microenvironment's role in cancer at all stages.
Main Methods:
- Funding initiatives spanning cancer biology.
- Supporting technology development.
- Promoting convergence of physical sciences and oncology.
- Advancing systems biology approaches.
Main Results:
- Enhanced understanding of the tumor microenvironment's role in cancer progression.
- Improved insights into mechanisms of therapeutic resistance.
Conclusions:
- Continued NCI funding is vital for advancing tumor microenvironment research.
- Interdisciplinary approaches are key to understanding cancer biology and resistance.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.